Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Biomarker Identification for Acute Coronary Syndrome via Integrating WGCNA and Machine Learning. | IET Syst Biol | 2025 | 41134682 | PubTator, text mining | PubMed |
| From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization. | Cell Commun Signal | 2025 | 41126244 | PubTator, text mining | PubMed |
| Targeting phosphofructokinase 2 the isoform PFKFB4 suppresses glioblastoma proliferation and malignancy. | Genes Genomics | 2025 | 41118116 | PubTator, text mining | PubMed |
| Differential expression of glycolysis-related genes and their potential immune mechanisms in acute myocardial infarction. | J Cardiothorac Surg | 2025 | 41107998 | PubTator, text mining | PubMed |
| Bioinformatic analysis and experimental validation of hub autophagy-related genes as novel biomarkers for type 2 diabetes mellitus and Alzheimer's disease. | PeerJ | 2025 | 41081092 | PubTator, text mining | PubMed |
| The role of glycolysis in MASLD development: Pathogenesis and therapeutic strategies. | Pharmacol Res | 2025 | 41077164 | PubTator, text mining | PubMed |
| Kickstart the cell cycle with a sugar boost: mTOR brake on APC/C-CDH1 triggers a glycolytic pulse. | Dev Cell | 2025 | 41056905 | PubTator, text mining | PubMed |
| Rewiring the mTOR, CDH1, APC/C, PFKFB3 axis: a glycolytic pulse to ignite the G0/G1 gateway. | Cell Cycle | 2025 | 41024585 | PubTator, text mining | PubMed |
| Adiponectin pathway regulates cerebral metabolic dysfunction and neuroinflammation via the AdipoR1/PI3K/Akt axis in Perioperative Neurocognitive Disorder. | BMC Geriatr | 2025 | 41013296 | PubTator, text mining | PubMed |
| Cantharidic acid inhibits the malignant progression of colorectal cancer by inhibiting aerobic glycolysis and regulating the PI3K/Akt/P53 pathway. | Pak J Pharm Sci | 2025 | 40996179 | PubTator, text mining | PubMed |
| Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. | J Transl Med | 2025 | 40993625 | PubTator, text mining | PubMed |
| Bioactivity Deep Learning for Complex Structure-Free Compound-Protein Interaction Prediction. | J Chem Inf Model | 2025 | 40957089 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism. | Cancer Med | 2025 | 40956032 | PubTator, text mining | PubMed |
| HBV Precore G1896A Mutation Promotes Malignancy of Hepatocellular Carcinoma by Activating Endoplasmic Reticulum Stress to Enhance Aerobic Glycolysis. | MedComm (2020) | 2025 | 40919132 | PubTator, text mining | PubMed |
| Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroinflammation via the NF-κB Signaling Pathway and HIF1α-Mediated Metabolic Reprogramming. | FASEB J | 2025 | 40911376 | PubTator, text mining | PubMed |
| Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammation. | Eur Heart J Open | 2025 | 40904944 | PubTator, text mining | PubMed |
| Impacts of aging and fluid shear stress on vascular endothelial metabolism and atherosclerosis development. | J Biomed Sci | 2025 | 40890841 | PubTator, text mining | PubMed |
| Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | 40884151 | PubTator, text mining | PubMed |
| PFKFB3-Mediated Glycolytic Metabolic Reprogramming Regulates Inflammatory Response in Dry Eye Disease. | Invest Ophthalmol Vis Sci | 2025 | 40879294 | PubTator, text mining | PubMed |
| From mitochondria to immune networks: new mesenchymal stem cell strategies to treat periodontitis. | Stem Cell Res Ther | 2025 | 40877977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=9